• Users Online: 37
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2020  |  Volume : 14  |  Issue : 4  |  Page : 73-84

Understanding COVID-19 in light of Ayurveda and exploring possible role of immune booster Kashaya in its management


Department of Kayachikitsa, National Institute of Ayurveda, Jaipur, Rajasthan, India

Correspondence Address:
Ram Kishor Joshi
Department of Kayachikitsa, National Institute of Ayurveda, Amer Road, Jaipur - 302 002, Rajasthan
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/joa.joa_130_20

Rights and Permissions

Background: A new virus of corona family known as novel coronavirus causes coronavirus disease 2019 (COVID-19) also known severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). A good number of principles are found in the classical texts of Ayurveda, which can be compared with the concepts of SARS-CoV-2, and many herbal drugs written in the Ayurvedic text, through its immunomodulatory effect, may enhance host–defense mechanism against such diseases to decrease the mortality. Aim: Our objectives of this review are (i) to understand the concepts of SARS-CoV-2 in light of Ayurveda with their approximate delineation through theoretical analysis; (ii) to review the role of Immune Booster Kashaya Special (IBKS) in boosting and regulating immunity and in preventing complications; and (iii) to explore the effectiveness of each drug among scientific community to facilitate for their extensive research. Methodology: We also searched for relevant keywords in various texts of Ayurveda as well as on online databases such as PubMed, Science Direct, Scopus, CrossRef, and Google Scholar to understand the concepts of SARS-CoV-2 in light of Ayurveda and to explore the possible role of 14 medicinal plants of “immune booster Kashaya” formulation. Result: We found that SARS-CoV-2 is symptomatically very much similar to Sannipataj Jwar as described in Ayurveda and the content of IBKS possesses antiviral, immunomodulatory, antioxidant, antipyretic, anti-inflammatory, cardioprotective, antianxiety, and phagocytic properties. It seems to promote the body's immune mechanism against viral activity and to prevent complications such as inflammation-induced damage and cytokine storming in COVID-19. Conclusion: As there is a lack of an effective SARS-CoV-2 virus-specific medicine or vaccine, these immunomodulatory strategies may be implemented before or shortly after viral exposure and may be paired with antiviral therapies to improve antiviral immune responses by providing interferon-inducing agents or by nonspecific boosting of immunity with innate factors. Immune booster Kashaya should be gone through extensive in vivo and in vitro studies and clinical trials for further validation.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed297    
    Printed10    
    Emailed0    
    PDF Downloaded23    
    Comments [Add]    

Recommend this journal